Résultats de la recherche - 8 results
Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European Region from December, 2020, to March, 2023: a retrospective surveillance study.
years). To be included in the analysis, CAT needed to have reported both COVID-19 vaccination and mortality data for at least one of the four older age groups. Only CAT that reported weekly data for both ...
A survey of the representativeness and usefulness of wastewater-based surveillance systems in 10 countries across Europe in 2023
brings understanding the diverse landscape of WBS in Europe, offering insights for future developments and collaborations. Furthermore, it highlights the need for further integration of WBS into other ...
Population health information research infrastructure—from data to public health actions
Information Research Infrastructure (PHIRI). The EU and its Member States need strong and resilient HIS that can deliver timely, sound and high-quality health information to support policymaking, strengthen ...
BY-COVID Educational Toolkit
to specific needs. Health Topics: Coronavirus Coronavirus Coronavirus Service: Centre du cancer Kankercentrum Cancer centre Manuscript versions: DOI: https://doi.org/10.5281/zenodo.8363521 File: Version: ...
Time series modelling for wastewater-based epidemiology of COVID-19: A nationwide study in 40 wastewater treatment plants of Belgium, February 2021 to June 2022
needs validation. Health Topics: Health and disease monitoring Coronavirus Surveillance de la santé et des maladies Ziekten en gezondheid in kaart brengen Coronavirus Coronavirus Service: Épidémiologie des maladies ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
that further boosting might be needed to achieve optimal protection against variants of concern in this vulnerable population group. Health Topics: Coronavirus Coronavirus Coronavirus Manuscript ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)
prevalence of anti- SARS-CoV-2 antibodies increased in wave 2 from 22.5% (27/09-24/10) to 36.5% (25/10-21/11). However, caution is needed to interpret these figures, because in wave 2 the number of ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study
explained by socioeconomic differences in the prevalence of chronic diseases. Further research is needed to explore if this difference could be related to a lower immune response of people with certain ...